We serve Chemical Name:2-pyridin-4-ylquinoline-4-carbohydrazide CAS:5206-34-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-pyridin-4-ylquinoline-4-carbohydrazide
CAS.NO:5206-34-8
Synonyms:2-Pyridin-4-yl-quinoline-4-carboxylic acid hydrazide
Molecular Formula:C15H12N4O
Molecular Weight:264.28200
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.303g/cm3
Index of Refraction:1.688
PSA:80.90000
Exact Mass:264.10100
LogP:2.99150
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Pyridin-4-yl-quinoline-4-carboxylic acid hydrazide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Pyridin-4-yl-quinoline-4-carboxylic acid hydrazide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Pyridin-4-yl-quinoline-4-carboxylic acid hydrazide Use and application,2-Pyridin-4-yl-quinoline-4-carboxylic acid hydrazide technical grade,usp/ep/jp grade.
Related News: For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. H-Asn-Asn-Tyr-OMe * CH3COOH manufacturers In recent years, it has benefited significantly from the development of a broad range of enabling technologies, leading biocatalysis to become an established methodology for efficient, sustainable manufacturing, especially within the drug development industry. (E)-2-methoxy-6-(oct-1-en-1-yl)naphthalene suppliers For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. 2-methoxy-17-methyl-6,14-dihydro-5H-6,14a-[1]azapropano-naphtho[1,2-b]phenazin-1-ol vendor & factory With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris. ,The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention.
